Srdjan R. Stankovic
2018
In 2018, Srdjan R. Stankovic earned a total compensation of $5.7M as President at ACADIA Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $334,289 |
|---|---|
| Option Awards | $4,094,313 |
| Salary | $524,785 |
| Stock Awards | $705,700 |
| Other | $19,294 |
| Total | $5,678,381 |
Stankovic received $4.1M in option awards, accounting for 72% of the total pay in 2018.
Stankovic also received $334.3K in non-equity incentive plan, $524.8K in salary, $705.7K in stock awards and $19.3K in other compensation.
Rankings
In 2018, Srdjan R. Stankovic's compensation ranked 1,699th out of 14,244 executives tracked by ExecPay. In other words, Stankovic earned more than 88.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,699 out of 14,244 | 88th |
Division Manufacturing | 603 out of 5,765 | 90th |
Major group Chemicals And Allied Products | 193 out of 2,128 | 91st |
Industry group Drugs | 153 out of 1,817 | 92nd |
Industry Pharmaceutical Preparations | 114 out of 1,391 | 92nd |
Source: SEC filing on April 30, 2021.
Stankovic's colleagues
We found three more compensation records of executives who worked with Srdjan R. Stankovic at ACADIA Pharmaceuticals in 2018.